Over the last 12 months, PanCAN stood in strong opposition to the administration’s threats to severely reduce federal funding ...

The Thai milita­ry said it had recovered a trove of evidence of transnational fraud from a Cam­bodian scam compound seized during clashes last year between the two countries along their disputed ...

Telecom software provider Amdocs (NASDAQ:DOX) in Q4 CY2025, with sales up 4.1% year on year to $1.16 billion. Its non-GAAP ...

Engineering and automation solutions company Emerson (NYSE:EMR) in Q4 CY2025, with sales up 4.1% year on year to $4.35 billion. Its non-GAAP profit of $1.46 per share was 3.4% above analysts’ ...

Starting July 4, parents will be able to open a Trump account for any child under 18 who has a Social Security number. Parents can deposit up to $5,000 a year into a fund that tracks the growth of the ...

With a new year underway, it’s a good time to start setting your goals for how much you’ll contribute to your retirement ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” Q4 2025 investor ...

Misinformation around menopause is still frustratingly common—among both doctors and patients. We asked experts why you ...

Compounding can build wealth. Resilience can protect it. Together, they can anchor long-term success. In today’s uncertain world, betting on a concentrated portfolio may be a risky gamble. Diversify ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from ...

Discover what interest-on-interest means, how it's calculated, and its impact in bond investing. Learn the difference between ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?